Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway

作者: Jie Zhang , Yong Choi , Blanche Mavromatis , Alan Lichtenstein , Weiqun Li

DOI: 10.1038/SJ.ONC.1206718

关键词:

摘要: We recently reported that internal deletion of PTEN tumor suppressor gene in OPM2 and Δ47 myeloma lines led to high Akt activation. Re-expression induced strong apoptosis growth inhibition. To understand the biologic importance phosphatidylinositol 3 kinase (PI3K)/Akt activation affected by deletion, we analysed inhibition applying PI3K inhibitors expressing constructs. The preferentially suppressed PTEN-null those PTEN, indicating is more critical for survival with mutations than others a functional gene. Since exhibited much stronger PTEN-expressing cells response insulin-like factor I stimulation, determined whether could be responsible PI3K-mediated cell lines. Expression an active Akt, but not its dead mutant, reversed wortmannin- dexamethasone-induced lines, suggesting lies downstream dexamethasone resistance. In summary, have provided evidence are stringently dependent on PI3K/Akt survival. These results may provide basis treat patients inhibitors.

参考文章(27)
Norihiro Nishimoto, Yoshihito Shima, Kazuyuki Yoshizaki, Tadamitsu Kishimoto, MYELOMA BIOLOGY AND THERAPY: Present Status and Future Developments Hematology-oncology Clinics of North America. ,vol. 11, pp. 159- 172 ,(1997) , 10.1016/S0889-8588(05)70421-4
Teresa Hyun, Alan Yam, Salvatore Pece, Xiaozhen Xie, Jie Zhang, Toru Miki, J. Silvio Gutkind, Weiqun Li, Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood. ,vol. 96, pp. 3560- 3568 ,(2000) , 10.1182/BLOOD.V96.10.3560
Alex Toker, Lewis C. Cantley, Signalling through the lipid products of phosphoinositide-3-OH kinase Nature. ,vol. 387, pp. 673- 676 ,(1997) , 10.1038/42648
D. R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, B. A. Hemmings, Mechanism of activation of protein kinase B by insulin and IGF-1. The EMBO Journal. ,vol. 15, pp. 6541- 6551 ,(1996) , 10.1002/J.1460-2075.1996.TB01045.X
Michael Hallek, P. Leif Bergsagel, Kenneth C. Anderson, Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process Blood. ,vol. 91, pp. 3- 21 ,(1998) , 10.1182/BLOOD.V91.1.3
Yijiang Shi, Jung-hsin Hsu, Liping Hu, Joseph Gera, Alan Lichtenstein, Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. Journal of Biological Chemistry. ,vol. 277, pp. 15712- 15720 ,(2002) , 10.1074/JBC.M200043200
Eugene S. Kandel, Nissim Hay, The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Experimental Cell Research. ,vol. 253, pp. 210- 229 ,(1999) , 10.1006/EXCR.1999.4690
L. C. Cantley, B. G. Neel, New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 4240- 4245 ,(1999) , 10.1073/PNAS.96.8.4240
Rena Feinman, Jeffrey Sawyer, James Hardin, Guido Tricot, CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMA Hematology-oncology Clinics of North America. ,vol. 11, pp. 1- 25 ,(1997) , 10.1016/S0889-8588(05)70412-3